Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Britt Van Renterghem

3PUBLICATIONS

9CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 27, 2022

Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.

Britt Van Renterghem, Agnieszka Wozniak, Patricia Garrido Castro

|Apr 23, 2022

Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma.

Britt Van Renterghem, Agnieszka Wozniak, Ludovica Tarantola

|Feb 12, 2022

PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.

Andrea Casazza, Lawrence Van Helleputte, Britt Van Renterghem

Pageof 1

Frequent Collaborators

3 joint publications

Patrick Schöffski

2 joint publications

Andrea Casazza

2 joint publications

Agnieszka Wozniak

1 joint publications

Lawrence Van Helleputte

1 joint publications

Peter Pokreisz

1 joint publications

Carla Riera-Domingo

1 joint publications

Olivier Defert

1 joint publications

Ludovica Tarantola

1 joint publications

Che-Jui Lee

Frequent Collaborators

3 joint publications

Patrick Schöffski

2 joint publications

Andrea Casazza

2 joint publications

Agnieszka Wozniak

1 joint publications

Lawrence Van Helleputte

Top Related Videos

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on : Jun 15, 2020

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>

Published on : Mar 18, 2014

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on : Jun 23, 2020

See more related videos

Top Related Videos

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on : Jun 15, 2020

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>

Published on : Mar 18, 2014

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on : Jun 23, 2020

See more related videos